CinCor Pharma Inc. (CINC) NASDAQ
$29.06 (0.14) (-0.48%)
Market Cap: -
As of 02/23/23 04:00 PM EST. Market closed.
CinCor Pharma Inc. (CINC)
NASDAQ
$29.06
(0.14) (-0.48%)
Market Cap: -
As of 02/23/23 04:00 PM EST. Market closed.
CinCor Pharma Inc. is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. The companys focus is on cardiovascular, metabolic and kidney diseases. CinCor Pharma was founded by Jon Isaacsohn, M.D., and Catherine Pearce, DHSc, MBA, in ... read more
CinCor Pharma Inc. is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. The companys focus is on cardiovascular, metabolic and kidney diseases. CinCor Pharma was founded by Jon Isaacsohn, M.D., and Catherine Pearce, DHSc, MBA, in 2018. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
HEALY JAMES | Director | Nov 28, 2022 | Sale | $14.32 | 6,000 | 85,920 | 0 | Feb 27, 2023, 09:15 PM |
Freeman Mason | Chief Medical Officer | Jun 10, 2022 | Sale | $15.21 | 6 | 91 | 2,494 | Feb 27, 2023, 05:10 PM |
Pearce Catherine | Chief Operating Officer | Jan 11, 2023 | Option Exercise | $28.75 | 3,997 | 114,914 | 140,149 | Jan 19, 2023, 04:34 PM |
5AM Partners VI, LLC | 10% Owner | Aug 15, 2022 | Buy | $30.00 | 112,667 | 3,380,010 | 3,953,990 | Aug 17, 2022, 08:01 PM |
5AM Partners VI, LLC | 10% Owner | Aug 15, 2022 | Buy | $30.00 | 487,333 | 14,619,990 | 487,333 | Aug 17, 2022, 08:01 PM |
Sofinnova Partners SAS | 10% Owner | Aug 15, 2022 | Buy | $30.00 | 133,333 | 3,999,990 | 4,220,979 | Aug 17, 2022, 04:19 PM |
Sofinnova Venture Partners X, L.P. | 10% Owner | Aug 11, 2022 | Buy | $30.00 | 500,000 | 15,000,000 | 6,073,949 | Aug 15, 2022, 03:46 PM |
HEALY JAMES | Director | Aug 11, 2022 | Buy | $30.00 | 6,000 | 180,000 | 6,000 | Aug 15, 2022, 03:45 PM |
HEALY JAMES | Director | Aug 11, 2022 | Buy | $30.00 | 500,000 | 15,000,000 | 6,073,949 | Aug 15, 2022, 03:45 PM |
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. | 10% Owner | Aug 11, 2022 | Buy | $30.00 | 83,000 | 2,490,000 | 4,209,470 | Aug 15, 2022, 02:22 PM |
GENERAL ATLANTIC, L.P. | 10% Owner | Aug 11, 2022 | Buy | $30.00 | 83,000 | 2,490,000 | 4,209,470 | Aug 15, 2022, 02:21 PM |
HEALY JAMES | Director | Aug 05, 2022 | Option Exercise | $13.60 | 29,411 | 399,990 | 29,411 | Aug 08, 2022, 12:57 PM |
GENERAL ATLANTIC GENPAR (BERMUDA), L.P. | 10% Owner | Jan 11, 2022 | Buy | $16.00 | 1,700,000 | 27,200,000 | 4,126,470 | Jan 13, 2022, 09:32 PM |
GENERAL ATLANTIC, L.P. | 10% Owner | Jan 11, 2022 | Buy | $16.00 | 1,700,000 | 27,200,000 | 4,126,470 | Jan 13, 2022, 09:32 PM |
5AM Partners VI, LLC | 10% Owner | Jan 11, 2022 | Buy | $16.00 | 312,500 | 5,000,000 | 496,323 | Jan 13, 2022, 04:45 PM |
5AM Partners VI, LLC | 10% Owner | Jan 11, 2022 | Buy | $16.00 | 157,500 | 2,520,000 | 3,841,323 | Jan 13, 2022, 04:45 PM |
Sofinnova Venture Partners X, L.P. | 10% Owner | Jan 11, 2022 | Buy | $16.00 | 325,000 | 5,200,000 | 5,573,949 | Jan 13, 2022, 04:38 PM |
Sofinnova Partners SAS | 10% Owner | Jan 11, 2022 | Buy | $16.00 | 220,000 | 3,520,000 | 4,087,646 | Jan 13, 2022, 04:36 PM |
HEALY JAMES | Director | Jan 11, 2022 | Buy | $16.00 | 325,000 | 5,200,000 | 5,573,949 | Jan 13, 2022, 04:33 PM |
Pearce Catherine | Chief Operating Officer | Jan 11, 2022 | Buy | $16.00 | 1,500 | 24,000 | 1,500 | Jan 13, 2022, 04:31 PM |
Pearce Catherine | Chief Operating Officer | Jan 11, 2022 | Buy | $16.00 | 750 | 12,000 | 130,911 | Jan 13, 2022, 04:31 PM |
Freeman Mason | EVP Clinical Development | Jan 11, 2022 | Buy | $16.00 | 100 | 1,600 | 100 | Jan 13, 2022, 04:28 PM |
Freeman Mason | EVP Clinical Development | Jan 11, 2022 | Buy | $16.00 | 2,500 | 40,000 | 2,500 | Jan 13, 2022, 04:28 PM |
de Garidel Marc | Chief Executive Officer | Jan 11, 2022 | Buy | $16.00 | 12,500 | 200,000 | 12,500 | Jan 13, 2022, 04:26 PM |
Coelho Mary Theresa | EVP CFO & Chief BD Officer | Jan 11, 2022 | Buy | $16.00 | 100 | 1,600 | 100 | Jan 13, 2022, 04:24 PM |